發(fā)布時(shí)間：2018-03-17 07:14

  本文選題：甲狀腺微小乳頭狀癌　切入點(diǎn)：腔鏡甲狀腺手術(shù)　出處：《皖南醫(yī)學(xué)院》2017年碩士論文　論文類型：學(xué)位論文

【摘要】：目的:通過對(duì)比分析腔鏡甲狀腺手術(shù)與傳統(tǒng)開放甲狀腺手術(shù)在治療甲狀腺微小乳頭狀癌的臨床應(yīng)用相關(guān)指標(biāo)的差異,探討腔鏡甲狀腺手術(shù)治療甲狀腺微小乳頭狀癌的安全性及可行性,分析其優(yōu)勢(shì)及,明確腔鏡甲狀腺手術(shù)在治療甲狀腺微小乳頭狀癌的臨床應(yīng)用價(jià)值。方法:選擇2015年6月~2016年12月在皖南醫(yī)學(xué)院第一附屬醫(yī)院甲乳外科診斷甲狀腺微小乳頭狀癌的42例患者,分成兩組:觀察組(SET組)與對(duì)照組(TOT組),每組21例,SET組行腔鏡甲狀腺癌根治術(shù),TOT組行傳統(tǒng)開放甲狀腺癌根治術(shù),對(duì)比分析兩組術(shù)式在手術(shù)時(shí)間、手術(shù)出血量、術(shù)后拔管時(shí)間、術(shù)后并發(fā)癥數(shù)、炎癥因子(TNF-α、IL-17)、VAS評(píng)分(術(shù)后24小時(shí))、清掃淋巴結(jié)數(shù)、術(shù)后沖洗液找腫瘤細(xì)胞、住院時(shí)間、住院費(fèi)用情況,用SPSS 20.0統(tǒng)計(jì)軟件分別對(duì)其行卡方檢驗(yàn)或t檢驗(yàn)分析,探討其差異性。結(jié)果:所有手術(shù)均順利完成,SET組無中轉(zhuǎn)開放病例。兩組在術(shù)后拔管時(shí)間、清掃淋巴結(jié)數(shù)方面差異無統(tǒng)計(jì)學(xué)意義(P0.05),兩組均無術(shù)后出血、喉上神經(jīng)、喉返神經(jīng)損傷、甲狀旁腺損傷、氣管損傷等嚴(yán)重并發(fā)癥的發(fā)生。兩組術(shù)后并發(fā)癥數(shù)方面的差異無統(tǒng)計(jì)學(xué)意義(P0.05);SET組的手術(shù)時(shí)間明顯高于TOT組(P0.01),而手術(shù)出血量、VAS評(píng)分明顯低于TOT組(P0.01)。兩種手術(shù)方式相比,SET組術(shù)后第三天IL-17濃度低于術(shù)后第一天(P0.01);TOT組術(shù)后第三天IL-17濃度低于術(shù)后第一天(P0.01);手術(shù)方式對(duì)IL-17的濃度沒有顯著影響(F=0.039,P=0.844),SET組術(shù)后與TOT組術(shù)后IL-17濃度差異不具有統(tǒng)計(jì)學(xué)意義。SET組術(shù)后第三天TNF-α含量低于術(shù)后第一天(P0.01);TOT組術(shù)后第三天TNF-α含量低于術(shù)后第一天(P0.01);手術(shù)方式對(duì)TNF-α的濃度沒有顯著影響(F=0.593,P=0.446),SET組術(shù)后與TOT組術(shù)后TNF-α含量差異不具有統(tǒng)計(jì)學(xué)意義。SET組手術(shù)病人,手術(shù)后手術(shù)腔沖洗液均未發(fā)現(xiàn)腫瘤細(xì)胞。兩組患者住院時(shí)間差異無統(tǒng)計(jì)學(xué)意義(P0.05),而SET組的住院費(fèi)用明顯高于TOT組(P0.01)。對(duì)兩組患者術(shù)后隨訪,進(jìn)行甲狀腺功能及甲狀腺彩超檢查,目前未發(fā)現(xiàn)局部復(fù)發(fā)或淋巴結(jié)轉(zhuǎn)移情況。結(jié)論:對(duì)于PTMC患者,行腔鏡甲狀腺癌根治術(shù)可達(dá)到與傳統(tǒng)開放手術(shù)相同的手術(shù)范圍,美容效果好,出血量少,并發(fā)癥的發(fā)生幾率相似。腔鏡甲狀腺手術(shù)治療PTMC時(shí)對(duì)機(jī)體的應(yīng)激狀態(tài)改變與開放手術(shù)相比差異無統(tǒng)計(jì)學(xué)意義。腔鏡甲狀腺手術(shù)治療PTMC是安全的手術(shù)方式,可完整清掃中央?yún)^(qū)淋巴結(jié),可在臨床上推廣應(yīng)用。
[Abstract]:Objective: to compare the clinical application of endoscopic thyroid surgery and traditional open thyroid surgery in the treatment of thyroid micropapillary carcinoma. To investigate the safety and feasibility of endoscopic thyroid surgery in the treatment of thyroid micropapillary carcinoma. To determine the clinical value of endoscopic thyroid surgery in the treatment of thyroid micropapillary carcinoma. Methods: from June 2015 to December 2016, 42 cases of thyroid micropapillary carcinoma were diagnosed by thyroid surgery in the first affiliated Hospital of Southern Anhui Medical College. Two groups were divided into two groups: observation group (set group) and control group (tot group). 21 patients in each group were treated with endoscopic radical thyroidectomy and tot group received traditional open radical thyroidectomy. The operative time, blood loss and extubation time were compared between the two groups. The number of postoperative complications, the inflammatory factor TNF- 偽 IL-17 / VAS score (24 hours after operation, the number of lymph nodes dissected, the amount of washing fluid after operation to find tumor cells, the length of stay, and the cost of hospitalization were analyzed by chi-square test or t-test with SPSS 20.0 statistical software). Results: all the operations were completed successfully in the set group. There were no cases in the two groups. There was no significant difference in the extubation time and the number of lymph nodes dissected between the two groups (P 0.05). There was no postoperative hemorrhage, injury of the superior laryngeal nerve and recurrent laryngeal nerve in the two groups. Parathyroid injury, There was no significant difference in the number of postoperative complications between the two groups. The operative time in the set group was significantly higher than that in the TOT group, and the VAS score was significantly lower than that in the TOT group. The IL-17 concentration on the third day after operation in the set group was lower than that on the third day after operation in the P0.01TOT group, and the IL-17 concentration on the third day after operation was lower than that on the first day after operation, and there was no significant difference in the concentration of IL-17 between the two groups. There was no statistical difference between the postoperative IL-17 concentration of the two groups and that of the TOT group. The content of TNF- 偽 in the set group on the third day after operation was lower than that in the first day after operation, and the level of TNF- 偽 in the set group on the third day after operation was lower than that in the first day after operation, and the level of TNF- 偽 was not significantly affected by the operation method. There was no significant difference in the content of TNF- 偽 between the TOT group and the group of TOT on the third day after operation. Statistical significance. Set group of surgical patients, No tumor cells were found in the flushing fluid of the operation cavity after operation. There was no significant difference in the hospitalization time between the two groups, but the hospitalization cost in the SET group was significantly higher than that in the TOT group (P 0.01). No local recurrence or lymph node metastasis was found at present. Conclusion: for PTMC patients, endoscopic radical thyroidectomy can achieve the same surgical scope as traditional open surgery, with good cosmetic effect and less bleeding. The incidence of complications was similar. There was no significant difference in stress state between endoscopic thyroidectomy and open surgery in the treatment of PTMC. Endoscopic thyroidectomy was a safe surgical method for the treatment of PTMC. The central lymph nodes can be completely dissected and can be popularized and applied in clinic.
【學(xué)位授予單位】：皖南醫(yī)學(xué)院
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R736.1

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 孫榮華;潘先均;蘇新良;呂清建;吳凱南;;甲狀腺乳頭狀癌頸部淋巴結(jié)轉(zhuǎn)移特點(diǎn)及清掃策略[J];中國癌癥雜志;2016年01期

2 馮萍;馬立;余一平;方靜;陳曦;夏苗火;徐潔;;全乳暈入路與胸乳入路腔鏡甲狀腺手術(shù)臨床對(duì)比研究[J];實(shí)用醫(yī)學(xué)雜志;2015年14期

3 王平;王勇;;腔鏡技術(shù)在甲狀腺癌治療中合理應(yīng)用[J];中國實(shí)用外科雜志;2015年06期

4 李忠海;王雪冬;尹秀珍;馬榮蘭;;甲狀腺腫瘤普外科手術(shù)臨床療效觀察[J];河北醫(yī)學(xué);2015年05期

5 胡金華;孫文海;孫彥;陳志俊;李薇;梁大鵬;黃沂傳;吳圓圓;華輝;;中央?yún)^(qū)淋巴結(jié)清掃術(shù)在治療甲狀腺乳頭狀癌的意義[J];中華臨床醫(yī)師雜志(電子版);2015年09期

6 胡嵩;孫圣榮;劉黎明;嚴(yán)勝云;陳怡發(fā);陳加新;;經(jīng)乳暈入路腔鏡與開放甲狀腺切除術(shù)治療甲狀腺良性病變效果分析[J];檢驗(yàn)醫(yī)學(xué)與臨床;2014年23期

7 劉洪濤;蔡相軍;劉亮;王斌;印慨;鄭成竹;;經(jīng)胸壁入路腔鏡甲狀腺切除術(shù)與開放手術(shù)的臨床對(duì)比分析[J];中華腔鏡外科雜志(電子版);2014年05期

8 林嘉;;腺葉切除術(shù)治療甲狀腺結(jié)節(jié)的優(yōu)勢(shì)臨床分析[J];中外醫(yī)學(xué)研究;2014年30期

9 齊慶安;張曉輝;王錦波;;經(jīng)乳暈入路內(nèi)鏡下甲狀腺腫瘤切除的手術(shù)技巧探討[J];實(shí)用醫(yī)藥雜志;2014年09期

10 王卓穎;吳毅;;分化型甲狀腺癌的診治指南解讀[J];外科理論與實(shí)踐;2014年03期

，

本文編號(hào)：1623700